Skip to main content
Clinical Trials/IRCT20211208053331N1
IRCT20211208053331N1
Completed
Phase 2

Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticism

Ahvaz University of Medical Sciences0 sites172 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
euroticism or neuroticism.
Sponsor
Ahvaz University of Medical Sciences
Enrollment
172
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Neuroticism traits based on NEO\-60 questionnaire with a score higher than 24
  • ?Age\-range 24\-45 years old
  • Obtaining informed consent from the individuals

Exclusion Criteria

  • Pregnancy or intention to conceive
  • Presence of psychiatric disorder based on GHQ questionnaire with a score above 23
  • Previous history of SSRI antidepressant intolerance
  • Patients with severe side effects of citalopram
  • Patients with a history of chronic diseases such as brain and heart disease, vascular, seizures
  • People with a history of drug abuse.

Outcomes

Primary Outcomes

Not specified

Similar Trials